Long-term survivors of allogeneic bone marrow transplantation experience financial and occupational costs that should be discussed when treatment is being considered, a Sydney study has found. PhD student Gemma Dyer, from the Kolling Institute, said almost 600 Australians have an allogeneic BMT each year. “They are most often for leukaemia, but the range of indications ...
Bone marrow transplants can have a profound financial impact on patients
By Tony James
15 Nov 2016